You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海南海藥(000566.SZ):子公司注射用頭孢唑肟鈉通過仿製藥質量和療效一致性評價

格隆匯7月9日丨海南海藥(000566.SZ)公佈,公司全資子公司海口市製藥廠有限公司近日獲得國家藥品監督管理局覈準簽發的化學藥品“注射用頭孢唑肟鈉”的《藥品補充申請批準通知書》。

頭孢唑肟鈉是一種第三代廣譜半合成頭孢菌素類抗生素,具有廣泛的抗菌譜和較低的耐藥性,適用於敏感菌所致的下呼吸道感染、尿路感染、腹腔感染、盆腔感染、敗血癥、皮膚軟組織感染、骨和關節感染、肺炎鏈球菌或流感嗜血桿菌所致腦膜炎和單純性淋病等。頭孢唑肟鈉具有抗菌譜廣、抗菌活性強、對β-內酰胺酶較穩定及對腎臟毒性小等特點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account